Combining two drug delivery strategies to improve bioavailability

Danish researchers hope to increase the bioavailability of low solubility drugs.

Elicera develops CAR-T against solid tumours – may become the first in the world

Today, there are five EU-approved CAR-T therapies, all focused on different types of blood cancer, but no one has yet succeeded in making the method work agains...

Cantargia avtalar om klinisk studie

Lundabaserade Cantargia och SMS-oncology tecknar avtal om genomförande av klinisk fas I/IIa-studie.

Finansierar forskning via sms

Ny tjänst lanserad vid Karolinska institutet.

Krönika: Collaboration across borders

Biosimilars bring price pressure, but are they sufficiently used?

When biosimilars were introduced just over 16 years ago, hopes were raised that they would give many more patients access to effective but otherwise extremely e...

Digital doktor i Norrbotten

På torsdag lanserar Region Norrbotten sin vårdtjänst Digitalen, för digital direktkontakt med sjuksköterska eller läkare.

Krönika: Can regulators keep up with innovation?

New technology has increased the understanding of disease mechanisms and enabled approval of products targeting small but specific patient populations; sometime...

Marie Gårdmark: Big data evidence generation drives change in the EU regulatory system

Rapid developments in technology have led to the possibility for the generation and analysis of vast volumes of data. Will the availability of big data lead to ...

Astra Zeneca’s Sweden CEO: “We have great faith in our portfolio”

It all started with a summer job as an operator at Astra’s chemical factory in Snäckviken, just outside Södertälje. More than three decades and countless differ...

Drug development creates new challenges for regulators

Swedish Healthtech Company 1928 Pushing Forward

The full service analytics platform is expanding the business.

They’re all doing it – buying drug research

December 12 the time has come for this year's annual partnering meeting Pharma Outsourcing in Stockholm. In Sweden this is a growing business, with Recipharm as...

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.

New firm based on SLU research

Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.

Algextrakt kan bli läkemedel

Algen Dunaliella salina klarar av att växa i några av jordens tuffaste miljöer, från saltgrottor i Antarktis till saltslätter i tropikerna och den innehåller må...

Peab-grundarens stiftelse ger 22 miljoner till life science

Nya behandlingmetoder av cancer, blodbrist och herpesvirus, nya tekniker för kartläggning av gener och upptäckt av sårinfektioner och ett växtbaserat järntillsk...

It´s time to establish relations

Communication with the patient is the key to future healthcare, writes Hanna Brodda, editor in chief of Life Science Sweden.

A world-class research village

Eight years ago, Medicon Village was set up in Lund. Since then, this hub for research, innovation and business has developed enormously, and today the life sci...

Så hittar du uppköpskandidater

Att investera i bolag på börsen som kan bli uppköpta kan vara en investeringsstrategi att få en snabb avkastning på sitt investerade kapital.

Pinar Koyuncu blir produktchef på CGM

Connectivity services på Compugroup medical har knutit Pinar Koyuncu till sig som produktchef.

640 miljoner till forskningsprojekt

Knut och Alice Wallenbergs Stiftelse har beviljat totalt 640 miljoner kronor till 22 forskningsprojekt varav flera inom medicin som bedöms ha möjlighet att leda...

Apple satsar på life science

Lanserar plattform för utveckling av appar som kan hjälpa forskare att samla in data och rekrytera patienter till kliniska studier.

Pengaregn över hälsoprojekt

22 projekt inom läkemedel, medtech och e-hälsa delar på 20,5 miljoner i Vinnova-utlysning.